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Abstract
The genome of influenza A viruses is constantly changing (genetic drift) resulting in small, gradual changes in viral proteins.
Alterations within antibody recognition sites of the viral membrane glycoproteins hemagglutinin (HA) and neuraminidase
(NA) result in an antigenetic drift, which requires the seasonal update of human influenza virus vaccines. Generally, virus
adaptation is necessary to obtain sufficiently high virus yields in cell culture-derived vaccine manufacturing. In this study
detailed HA N-glycosylation pattern analysis was combined with in-depth pyrosequencing analysis of the virus genomic
RNA. Forward and backward adaptation from Madin-Darby Canine Kidney (MDCK) cells to African green monkey kidney
(Vero) cells was investigated for two closely related influenza A virus PR/8/34 (H1N1) strains: from the National Institute for
Biological Standards and Control (NIBSC) or the Robert Koch Institute (RKI). Furthermore, stability of HA N-glycosylation
patterns over ten consecutive passages and different harvest time points is demonstrated. Adaptation to Vero cells finally
allowed efficient influenza A virus replication in Vero cells. In contrast, during back-adaptation the virus replicated well from
the very beginning. HA N-glycosylation patterns were cell line dependent and stabilized fast within one (NIBSC-derived
virus) or two (RKI-derived virus) successive passages during adaptation processes. However, during adaptation new virus
variants were detected. These variants carried ‘‘rescue’’ mutations on the genomic level within the HA stem region, which
result in amino acid substitutions. These substitutions finally allowed sufficient virus replication in the new host system.
According to adaptation pressure the composition of the virus populations varied. In Vero cells a selection for ‘‘rescue’’
variants was characteristic. After back-adaptation to MDCK cells some variants persisted at indifferent frequencies, others
slowly diminished and even dropped below the detection limit.
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Introduction
Influenza A virus is a highly virulent human and animal
pathogen, particularly due to its ability to cause severe disease.
Hygiene measures and vaccination still represent the most efficient
prevention strategies. Since several years cell culture-based
processes are being established to overcome problems of
traditional egg-based vaccine manufacturing such as egg supply
shortages and difficulties in rapid scale-up during pandemics, as
well as to increase manufacturing capacities. The need for the
seasonal reformulation of influenza vaccines is attributed to the
virus’ ability to rapidly adapt to changing environments. Virus
adaptation is one of the most important processes in virus
evolution, and a crucial factor to be taken into account for
seasonal and pandemic vaccine production. On the one hand,
adaptation allows the virus to cross species boarders, evade
immune or therapeutic pressures and optimize its replication in a
given host system [1]. On the other hand, it challenges
manufacturers to adapt emerging strains to existing egg-based or
cell-culture-based system processes to obtain maximum yields for
formulation of potent vaccines [2,3]. Escape from immune
pressure, balancing host cell receptor binding avidity of input
virus with the release of progeny virus as well as adjustment to
altered endosomal pH-values or to different, specific sialic acid
containing host cell receptors have been described as driving forces
for adaptation processes in virus evolution [2,4–6]. During the
initial step of infection the viral surface glycoprotein hemagglutinin
(HA) binds to host-specific sialic acid receptors [7]. The following
receptor-mediated endocytosis leads to a drop in pH-value,
causing conformational changes of the HA subunits that enable
the release of the viral RNA into the cytoplasm of the host cell [8].
Besides this key role in virus replication, HA is a highly abundant
protein in the membrane of the virus particle, and it represents the
major component in influenza vaccines due to its ability to induce
a strong and protective immune response [9,10].
Glycoproteins such as HA can be considered as a collection of
different glycoforms or glycosylation variants [11]. A glycopro-
tein’s characteristic is described by specific activity [12],
antigenicity [12–14], binding avidity [15] and specificity [16]. It
can be influenced significantly by changes, respectively, differences
in N-glycosylation, reflecting variations in glycosylation site
occupancy (macroheterogeneity) and in structure of sugar residues
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increased additionally by a co-existence of related virus subpop-
ulations on the genomic and therefore also on the proteomic level,
so-called quasispecies [17–19]. On the one hand, new influenza
variants can originate from the virus’ ability to newly reassort
(genetic shift) [20], which allows the generation of high-growth
reassortants in vaccine manufacturing [21]. On the other hand,
the high error rate of the viral polymerase raises constantly new
variants [22], which only differ in single or few amino acid
positions, resulting in variations of the virus genoms. Further,
natural selection leads to the adaptation of a given virus as an
evolutionary response to ‘‘new-host-pressure’’ [20]. The frequency
of a virus variant in a population largely depends on its ability to
survive and reproduce – i.e. its fitness [23]. However, if coupled to
high fitness genotypes, low fitness virus variants can be maintained
at higher levels than expected [24]. For vaccine manufacturing this
implies the requirement of multiple variant selection steps for virus
seed preparation. In general, human isolates replicate poorly in
eggs. In order to minimize the risk of contamination with other
human pathogens, clinical specimens of the strains recommended
for the next season’s vaccine formulation are usually blind-
passaged in embryonated chicken eggs by WHO Collaborating
Centers. Further process optimizations are performed by manu-
facturers. Here variants that replicate well are selected to be
reassorted to high-yield laboratory viruses to generate virus seeds
used in production. Due to possible antigenic drift during each of
these steps antigen identity testing and sequence analyses are
required [25,26].
In this study we investigated the stability of the HA N-
glycosylation pattern over 10 successive virus passages in Madin-
Darby canine kidney (MDCK) cell culture. In addition, HA-
stability was characterized for MDCK and Vero (African green
monkey kidney) cells for up to 96 hours post infection (hpi) and
360 hpi, respectively. Furthermore, the impact of adaptation from
MDCK to Vero cells and back on HA N-glycosylation and
composition of the virus population was studied. Therefore, two
closely related MDCK cell-adapted influenza A virus Puerto
Rico/8/34 (H1N1) strains were adapted to growth on Vero cells.
Resulting Vero cell-adapted viruses were subsequently back-
adapted to replicate in MDCK cells. Finally, the consequences
on HA level of different virus adaptation processes from MDCK
cell to Vero cell based production and back were monitored.
Therefore, detailed HA N-glycosylation pattern analysis of this
major vaccine antigen was combined with in-depth pyrosequenc-
ing analysis of the HA encoding RNA segment 4. This allowed a
characterization of quasispecies’ composition.
Materials and Methods
Cell lines
Adherent MDCK (No. 84121903) or Vero (No. 88020401) cells
were purchased from ECACC (Salisbury, UK). The cells were
either grown in T75- and T175- flasks at 5% CO2 and 37uCo ri n
roller bottles with closed caps at 37uC. For cell growth GMEM
(Invitrogen/Gibco, #22100-093, Darmstadt, Germany) was
supplemented with 5.5 g/L glucose (Roth, #X997.3, Karlsruhe,
Germany), 2 g/L peptone (IDG, #MC33, Lancashire, UK), 10%
FCS Invitrogen/Gibco, #10270-106, Darmstadt, Germany) and
4 mg/mL NaHCO3 (Roth, #6885.3, Karlsruhe, Germany).
Virus
Infections were performed with influenza A/Puerto Rico/8/34
(H1N1) from either the National Institute for Biological Standards
and Control (NIBSC, #06/114, South Mimms, UK) or the
Robert Koch Institute (RKI, Amp. 3138, Berlin, Germany)
according to Genzel et al. [27]. In the following these virus strains
are referred to as PR/8/34 (NIBSC) or PR/8/34 (RKI),
respectively. Briefly, for infection and virus production the
serum-free growth medium was supplemented with a final
concentration of 5 U/mL trypsin (Invitrogen/Gibco, #27250-
018, Darmstadt, Germany), which was prepared in phosphate
buffered saline (PBS) according to the activity given by the
supplier.
Virus growth for stability testing of HA N-glycosylation
pattern and cell line adaptation studies
All infections were performed when cells were confluent using
0.2 mL virus seed for T75 flasks, 0.4 mL for T175 flasks or 1 mL
for roller bottles (a volume-based passaging was chosen since the
time required for determination of the number of infectious virus
particles by TCID50 or plaque assays was too long for the
experimental setup). Furthermore, Genzel et al. showed that the
multiplicity of infection (moi) has no effect on final HA virus titers,
only on the time needed to reach this maximum HA value [28].
To generate the initial virus inoculum (passage 1), MDCK cell-
adapted virus seed was thawed and propagated for 24 h in
MDCK cells using a moi of 2 or 0.03 for PR/8/34 (RKI) and
(NIBSC), respectively. All successive passages (2 to 11) were
infected with virus culture supernatant of the previous cultivation
provided that HA-titers were above 1.8 log HA units/100 mL (1.8
HAU) - the minimal HA-titer required for N-glycan analysis.
Overall, the initial MDCK cell-adapted virus was passaged five
times in Vero cells and subsequently for back-adaptation up to five
times in MDCK cells. As a control the virus seed was passaged in
MDCK cells only (initial moi 0.3). In order to monitor the impact
of harvest time points, MDCK (initial moi 0.3) and Vero (initial
moi 0.1) cell-adapted virus seed was propagated in MDCK and
Vero cells, respectively and isolated at different time points within
the time frame of interest for MDCK as well as Vero cell-derived
virus. All controls were performed in roller bottles using PR/8/34
(RKI).
Hemagglutination assay
Influenza virus from cell culture supernatant was titrated by
hemagglutination based on the method by Kalbfuss et al. [29].
Samples were serially diluted 1:2
0.5 in PBS resulting in a final
volume of 100 mL using round-bottomed 96-well plates. 1.9–
2.1610
6 red blood chicken cells in a total volume of 100 mLi n
PBS were added and incubated for 3 h to 4 h at room
temperature. Light extinction was measured at 700 nm and
plotted over the logarithm of the inversed dilutions. The end point
was defined as the point of inflection - the last dilution (d) showing
complete hemagglutination - corresponding to 1 HAU (HAU =
HA Units = -log10 d/100 mL). A sample’s HA-titer is calculated
by considering the dilution factor of the end point. Consequently,
if e.g. the end point is reached at a dilution of 1/64 (1/10
1.8), this
corresponds to an HA-titer of 1.8 HAU for the undiluted sample.
Virus purification, N-glycan analysis and data evaluation
Virus purification by gradient step centrifugation, sample
preparation, N-glycan analysis and data evaluation were per-
formed according to Schwarzer et al. [30,31], but applying an
optimized protocol. This included the substitution of 20 mM
sodium hydrogen carbonate (aq) with 50 mM ammonium
hydrogen carbonate (aq) during enzymatic in-gel-deglycosylation
and N-glycan extraction as well as the reduction of the final sample
volume for PNGaseF-digestion to 60 mL, which resulted in an
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by size exclusion chromatography as described by Schwarzer et al.
[30]. Briefly, capillary gel electrophoresis with laser-induced
fluorescence detection (CGE-LIF) was performed in an ABI
PRISM 3100-Avant genetic analyzer (Applied Biosystems, Foster
City, California, USA). The purified samples were diluted in HiDi
formamide (#4311320C, Applied Biosystems, Foster City, Cali-
fornia, USA). The N-glycan pool of an HA sample was separated
by capillary gel electrophoresis, resulting in capillary electrophe-
rograms, which – after migration time normalization - corresponds
to the N-glycosylation pattern, in which relative fluorescence units
(RFU) are plotted over the normalized migration time (tmig) in base
pairs (bp). In N-glycosylation patterns, one peak corresponds to at
least one distinct N-glycan structure. The total peak height (TPH)
is calculated as the sum of all peaks and is set to 100%. Differences
in relative abundances are expressed in percentage of relative peak
height (RPH). Accordingly, overlays of multiple N-glycosylation
patterns allow a direct comparison of different HA N-glycan pools.
In the following peaks are annotated as shown in figure 1. Data
were processed as published previously [30–32].
Pyrosequencing and sequence assembly
Segment 4 (HA) of influenza A was sequenced using the
Genome Sequencer FLX instrument (Roche, Mannheim, Ger-
many). For DNA preparation the protocol of Ho ¨per et al. [33] was
applied with the modifications described by Leifer and colleagues
[34]. RT-PCR was conducted as described by Ho ¨per et al. [35].
For reverse transcription of the RNA genome segment, the
Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Mann-
heim, Germany) and for amplification of the cDNA the iProof
High-Fidelity Master Mix (Bio-Rad Laboratories GmbH,
Mu ¨nchen, Germany) was used. The sequencing libraries were
generated according to Wiley et al. [36] followed by DNA binding
to library capture beads and the recovery of single-stranded
template DNA (sstDNA) library. For bead-bound clonal amplifi-
cation, the DNA libraries were subjected to duplicate emulsion
PCRs (emPCR) with the GS emPCR kit I (Roche, Mannheim,
Germany), according to the manufacturer’s instructions (2 copies
per bead). After bead recovery and enrichment, the beads were
sequenced using a GS LR70 sequencing kit (Roche, Mannheim,
Germany) and the appropriate instrument run protocol provided
by the vendor. The resulting sequencing reads were sorted
according to the genome segments and assembled into one contig
(i.e., a set of overlapping sequencing reads) per segment using the
GS FLX sequence assembly software newbler (version 2.3; Roche,
Mannheim, Germany). During the assembly, primer sequences
were trimmed-off the raw data. All sequences were deposited in
the GISAID EpiFlu database (www.gisaid.org), the accession
numbers are compiled in the supplementary (table S1). For
quasispecies analysis, a mapping of the raw sequencing reads along
the reference sequence was performed using the GS FLX
reference mapper software (version 2.3; Roche, Mannheim,
Germany) with the default parameters (also during the mapping
primer sequences were trimmed off the raw data). Briefly, ’’high
confidence’’ differences were defined by a combination of flow
signal, quality score and difference type information: generally, at
least three non-duplicate reads with the difference are required.
Besides, there must be both forward and reverse reads showing the
difference, unless there are at least seven reads with quality scores
over 20. If the difference is a single-base over- or undercall (e.g.
CC instead of C, or A instead of AA), the reads with the difference
must form the consensus of the sequenced reads (i.e. at that
location the overall consensus must differ from the reference) and
the signal distribution of the differing reads must vary from the
matching reads and the number of bases in that homopolymer of
the reference (GS FLX Software Manual 2.17.1.14).
In the following, amino acid substitutions during the adaptation
processeswill be annotated by the one letteramino acid code for the
original residue (in passage 1), followed by the position number of
the residue, followed by the one letter codeof the substituting amino
acid in the later passage. Insertions and deletions are indicated by a
minus sign (-) at the first or last position, respectively.
Sample storage
Virus containing cell culture supernatants as well as virus
isolates were stored at 280uC; HA N-glycans for glycosylation
pattern analysis were stored at 220uC. Sealed Coomassie-stained
polyacrylamide gels with HA bands (#161-1155 or #161-1158,
BioRad, Hercules, Canada) were stored at 4uC.
Stability of HA N-glycosylation pattern over multiple
virus passages and over different harvest time points
One essential condition for the characterization of adaptation
processes of influenza viruses A/PR/8/34 (H1N1) to different host
cell lines is the stability of the HA N-glycosylation pattern over
multiple virus passages in one cell line. For MDCK cell-derived
PR/8/34 (RKI), HA-titers of 10 successive virus passages ranged
between 2 and 2.4 HAU at 24 hpi (data not shown). Furthermore,
all HA N-glycosylation patterns feature the same 15 main peaks
(no. 1-4, 6-16) throughout all passages (figure S1A). The standard
Figure 1. Peak annotation of MDCK and Vero cell-specific HA N-glycosylation patterns of influenza A/PR/8/34 (H1N1). Relative
fluorescence units (RFU) plotted over normalized migration time in basepairs (bp). The shifted overlay of the normalized capillary electropherograms,
represents MDCK cell-specific (black) and Vero cell-specific (red) glycosylation patterns.
doi:10.1371/journal.pone.0027989.g001
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S1B). Overall, these results demonstrate a high stability of the HA
N-glycosylation pattern over 10 successive virus passages in the
same host cell system.
Furthermore, previous experiments showed that for guaranteed
N-glycan analysis samples with a minimum HAU-value of 1.8 are
required (data not shown). With differences in replication
dynamics during adaptation to a new cell line, i.e. slow replication
dynamics during initial adaptation steps and fast progress of
infection towards the end, different time points for sampling were
required to achieve a minimum of 1.8 HAU. Hence, the impact of
harvest time point on HA N-glycosylation patterns was investigat-
ed for Vero cell-adapted PR/8/34 (RKI) virus in Vero cells, and
for MDCK cell-adapted virus in MDCK cells. For all sampling
points (24, 96 hpi) during MDCK cell-based virus replication, the
HA N-glycosylation pattern was dominated by the same 15 main
peaks (no. 1 - 4, 6 - 16; figure S2A), exhibiting SD for RPH
between 0% and 2.3% (figure S2B).
In contrast, the pattern from Vero cell-derived HA was defined
by 16 main peaks (no. 5, 7, 8, 11, 15 - 25, figure S3A). Regarding
the complete time span (sampling points 48, 96, 200, 360 hpi) the
SD for RPH ranged from 0.1% to 6% (figure S3B). Considering
only the time span until 96 hpi, SD comparable to the MDCK
time series were observed (SD,2.7%). Taking into account the
comparatively long sampling period of 360 h, the higher SD were
most likely caused by N-glycan degradation or synthesis. In
particular, the RPH of peaks 5 and 7 steadily increased (it almost
doubled for peak 7) and the RPH for peaks 16, 20, 22 to 25
steadily decreased over time. However, even despite those changes
of RPH, the HA N-glycosylation pattern itself was stable over
360 h.
Overall, results demonstrated a highly reproducible HA N-
glycosylation pattern for both cell lines concerning the number of
glycan structures. For Vero cells, but to a certain degree also for
MDCK cells (due to smaller time frame), the relative amounts
(RPH values) of single structures present in the glycan pool, were
dependant on the harvest time point of the virus-containing
supernatant.
Results and Discussion
Adaptation of PR/8/34 from MDCK to Vero cells and back
In2010Genzeletal.showedthatvirusesoftenrequireadaptation
to new host cells to optimize yields and time of harvest. In order to
further characterize this adaptation process and to investigate
possible biological mechanisms MDCK cell-adapted virus was
propagated for 24 h in MDCK cells (passage 1). As a result HA-
titers of 1.9 HAU and 2.2 HAU were obtained for the strains from
RKI and NIBSC, respectively (data not shown). Supernatant of this
passage served as the virus seed for a first infection of Vero cells
(passage 2).For the RKI-strain virus-release was not detected before
288hpi(0.8 HAU,figure2A)and the maximalHA-titerof1.4HAU
was finally reached 360 hpi. For the NIBSC-strain virus release was
first detected 216 hpi and virus replication was continued until 360
hpi, exhibiting a final HA-titer of 1.95 HAU (figure 2B). An aliquot
of these supernatants served as virus seeds for the next infections of
Vero cells (passage 3) and so on (passage 4 to 6). During this virus
adaptation to Vero cells, viral fitness of the RKI-strain improved:
The time required to achieve specific HAU-values ($ 1.4 HAU)
decreased, whereas maximum HA-titers increased from passage 2
to 4. No significant differences were detected for passage 4 to 6,
indicating the completion of the adaptation process (figure 2A). For
the NIBSC-strain, the second passage in Vero cells (passage 3)
reached 2.1 HAU at 120 hpi, and passage 4 reached 2.74 HAU at
96 hpi. For all subsequent passages the time required to achieve a
HA-titer of at least 1.8HAUas well asthe maximal titers were more
or less the same. This indicated the completion of the adaptation
process (figure 2B). The following five virus passages (7 to 11) were
again performed in MDCK cells to monitor virus back-adaptation.
Here, for the RKI- as well as the NIBSC-strain all titers ranged
between 2 HAU and 2.5 HAU and were reached between 48 hpi
and 96 hpi (data not shown). In contrast to the adaptation to Vero
cells, no impact on HA-titer level and virus release dynamics was
observed during back-adaptation.
Host cell-specificity of HA N-glycosylation patterns
All HA N-glycosylation patterns of MDCK cell-derived virus
samples were similar. The same applied to the Vero cell-derived
virus samples (figure 2C). In agreement with earlier studies the HA
N-glycosylation pattern was strictly host cell-specific and changed
significantly with the switch to the new host cells [28,31].
However, of all Vero cell-derived HA N-glycosylation patterns
for the RKI- as well as the NIBSC-strain passage 2 revealed the
biggest differences in RPH (figure 3A). Here, the RPH of peak 5
and 7 was almost twice as high as for all subsequent passages in
Vero cells. This is in agreement with the time series in Vero cells
(figure S3) where these RPH almost doubled until 360 hpi.
Furthermore, the low abundant glycan structure represented by
peak 11 was missing in passage 2 of both strains (figure 2B, D;
figure 3). This is most likely due to a drop below the detection
limit. During the adaptation of the RKI-strain the height of peak
16 decreased by a factor of two in passage 2 (figure 3A, figure 2C),
which was in agreement with the steady decrease of peak 16
during time course experiments (figure S3). Besides, peaks 17 and
18 were missing in passage 2 of the RKI-strain. In the time series
in Vero cells these peaks represented low abundant structures with
only 0.2 – 2.7% of TPH (figure S3). This probably indicates again
a drop below the detection limit.
For each peak in both host-specific glycosylation patterns a
comparison of the maximal SD in controls (biological replicates
and the time courses) with the SD observed during adaptation
experiments is shown in table S2. A more than 3-fold higher SD
compared to the controls was considered significant. For the RKI-
strain, during adaptation to Vero cells three peaks (11, 14 and 18)
showed a more than 3-fold higher SD of RPH (table S2;
Adaptation series H1N1, RKI) compared to the same peaks of
the time series experiment (figure S3). Closer examination of the
15 main peaks of all MDCK cell-derived HA N-glycosylation
patterns during back-adaptation revealed a more than 3-fold
higher SD in RPH for peaks 6 and 14 (table S2; Adaptation series
H1N1, RKI) compared to the respective time series and biological
reproducibility experiments (figure S3). Of these peaks, only
number 6, with an average RPH of 12.13%, represents a high
abundant glycan structure above 5% of the TPH. For the NIBSC-
strain, during forward adaptation, a 3-fold higher SD was found
for the high abundant glycan structure represented by peak 14
(RPH .5%), as well as for another low abundant glycan structure
represented by peak 19 (RPH ,5%). Regarding the back-
adaptation to MDCK cells the low abundant glycan structures
of peaks 7 and 14, as well as the high abundant glycan structures of
peak 6, 10 and 13 (RPH .5%) exhibited a more than 3-fold
higher SD compared to controls.
Overall, however, a clear trend duringthe forwardand backward
adaptation process was not evident (figure 2C, figure 3). Further-
more, good reproducibility of the host cell-specific HA N-
glycosylation pattern during virus adaptation to different host cell
lines was demonstrated for both PR/8/34 influenza virus strains.
Obviously,itis mainlythehostcell line whichdeterminestheHAN-
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point or the viral adaptation status have only a minor impact on the
respective RPH of glycan structures. Finally, the discrepancy of the
HA N-glycosylation pattern for NIBSC- as well as the RKI-virus
betweenthe first passage inVero cells (passage 2) and thepatterns of
all subsequent Vero cell adaptation passages (passages 3 – 6) can not
completely be explained by differing harvest time points and
remains to be further investigated.
Changes in quasispecies composition
To investigate the impact of forward and backward adaptations
in both cell lines segment 4 coding for the HA was sequenced for
passage 1, 6 and 11. Focus was in particular on changes in
potential HA N-glycosylation sites. The consensus sequences of
segment 4 of the initial, MDCK cell-derived virus seeds from
passage 1 are shown in the supplementary (figure S5). Regarding
the consensus amino acid sequences of HA, the initial virus seeds
from RKI and NIBSC differed in 7 amino acid positions. The
differences comprise K147-, A156E, E158K, I208L, R269M, F309Y
and S398T (RKI vs NIBSC, figure S5). For the RKI-strain,
sequencing analysis clearly indicated that the virus population
from the first initial MDCK passage 1 was uniform concerning
RNA segment 4, i.e. only one virus variant was detected above the
detection limit. In contrast segment 4 of the initial virus seed from
NIBSC (passage 1) already comprised several virus variants. The
following variants were detected with the specified frequencies
(table 1, B): Y24H (22%), T397A (1.3%), T397S (0.6%), D455Y
(21.4%) and N460D (12.2%).
After complete adaptation to Vero cells (passage 6), 80% of the
RKI-strain virus population carried amino acid substitution
K460E, where a positively charged lysine was replaced by the
negatively charged glutamic acid. Another population of 19%
carried the S457L substitution, where polar serine was replaced by
non-polar leucine (table 1A). These two substitutions were
uncoupled. No single read was detected, which carried both
substitutions. Hence, 99% of sequenced viruses carried either one
Figure 2. HA-titers and shifted overlays of HA N-glycosylation patterns during influenza virus A/PR/8/34 (H1N1) adaptation from
MDCK to Vero cells. MDCK cell-adapted virus seed from RKI (A) as well as from NIBSC (B) replicate poorly in the first Vero cell passage (¤, passage 2).
Passage (3) to (6) exhibit increased virus fitness (e, m, D, &). For the HA-assay the 95% confidence interval is maximum 15%. (C, D) The normalized capillary
electropherograms altogether represent 11 virus passages of the virus from RKI (C) and NIBSC (D): (1) virus seed, (2) to (6) adaptation to Vero cells, (7) to (11)
back-adaptation to MDCK cells. MDCK and Vero cell-derived HA N-glycosylation patterns dominated by 15 peaks and 16 peaks, respectively.
doi:10.1371/journal.pone.0027989.g002
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adaptation to efficient virus growth in Vero cells. Only single reads
were detected that carried the original sequence of the first
passage. This suggests that on the one hand, the initial virus did
replicate in Vero cells, but only poorly. Considering the dilutions
of the initial virus seed during the 5 Vero passages without any
replication, its concentration would have been below 0.1 virion/
mL in passage 6 and would most likely not have been detected at
all. On the other hand, only a change in very few single amino
acids in this HA-region is necessary to increase virus fitness for
sufficient growth in Vero cells. In passage 6 of the adaptation of
the NIBSC-strain a new variant carrying a V395M substitution
was detected with a frequency of 41.5%, which introduced an
additional sulfur containing residue into the HA2 peptide chain.
Furthermore, the D455Y virus seed subpopulation dropped to
6.1%, but a new variant D455H, in which aspartic acid was
substituted by the basic amino acid histidine, was detected that
dominated the virus population with 52%. In addition, the N460D
subpopulation increased to 41.1% (table 1B).
After back-adaptation of the RKI-strain to MDCK cells the
dominating virus population (81%) still carried the K460E
substitution in the HA. The minor subpopulation (19% after
Vero-adaptation) carrying the S457L substitution decreased to 9%
after back-adaptation. The remaining population of 10%
represented the initial virus seed sequence from passage 1
(table 1A). This demonstrates that the K460E variant allows good
virus replication in both cell lines. In contrast, the S457L variant
seems to be less efficiently replicating in MDCK cells. These
results, particularly the fitness of the K460E variant in MDCK as
well as in Vero cells, strongly suggests that a mutation in this
region was acquired, rather than an already existing virus
subpopulation of the initial virus seed was selected. This mutation
finally allowed sufficient virus replication in passage 2 of the
adaptation series to reach an HA-titer of 1.4 HAU at 288 hpi.
After back-adaptation of the NIBSC-strain to MDCK cells the
V395M, the D455Y, the D455H, and the N460D variants
decreased to 11.3%, 3.2%, 44.1%, and 10.5%, respectively. In
contrast, the T397S variant that was not detected in passage 6,
Figure 3. Relative peak heights of influenza A/PR/8/34 (H1N1) HA N-glycosylation patterns during virus adaptation. (A) for the isolate
from RKI: In passages (1) and (7) to (11) virus was propagated in MDCK cell culture (&). In passages (2) to (6) virus was propagated in Vero cell culture
(%). Most of the 25 different major peaks are host cell-specific. Only the HA N-glycan structures represented by peak no. 7, 8, 11, 14 to 16 and 19 to
21 are present in virus samples from both host cells. (B) for the isolate from NIBSC: In passage (1) and (7) to (11) virus was propagated in MDCK cell
culture (&). In passage (2) to (6) virus was propagated in Vero cell culture (%). Most of the 25 different major peaks are host cell-specific. The HA N-
glycan structures represented by peak no. 7, 8, 11, 14 to 16 and 19 to 21 are present in virus samples from both host cells.
doi:10.1371/journal.pone.0027989.g003
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This T397S substitution abolished the only difference of the
consensus sequences in the HA2 chain from the two influenza
viruses A/PR/8/34 (H1N1) strains from NIBSC and the RKI
(figure S5). Furthermore a new variant carrying the K459E
substitution was detected with a frequency of 44.2%.
All substitutions detected during adaptation of both A/PR/8/
34 (H1N1) strains are located in the HA2 chain, neither inside nor
in close proximity of any N-glycosylation site. They are, however,
located in the inside of the HA trimer within or in close proximity
to the fusion peptide pocket: within the subunits’ contact site for
the RKI-strain (figure S4A-D) and within the subunits’ and
monomer contact sites for the NIBSC-strain (figure S4E-H). This
position belongs to the fusion subdomain [37]. Substitutions in
this region of HA subunit contacts have been described to be
crucial for the stability of the structure of the native protein.
Among other factors, the optimal stability depends on pH or
temperature [2,38-40]. In this regard lower pH environments for
instance require higher native structure stability, whereas
elevated pH-values require less stable structure conformations
to mediate membrane fusion. In 2010 Reed et al. demonstrated
using recombinant H5N1 influenza viruses that substitutions
within the fusion peptide pocket and the a-helix of HA2 alter the
pH of activation of HA, which in term effects influenza virus
pathogenicity as well as transmissibility in mallards [41].
Furthermore, Thoennes et al. showed that different substitutions
at HA2 position 111 of a H3N2 influenza virus strain significantly
effected fusion pH, suggesting, a key role of this residue for
neutral pH structure stability [42]. Therefore, it remains to be
investigated, whether the substitutions occurring during the
adaptation processes from MDCK to Vero cell-based replication
and back alter acid stability of HA [43], pH of activation, or
membrane fusion [44]. Or, whether they simply counteract steric
hindrance [45] caused by Vero-specific changes in HA N-
glycosylation, e.g. on residues 28 and/or 40 in the stem region of
HA to achieve low-pH conformation required for membrane
fusion.
An alignment of the segment 4 sequence of the initial, MDCK
cell-derived virus PR/8/34 (RKI) from passage 1 with the viral
sequence published in 1981 [46] demonstrated homology with
three exceptions. These included a substitution at position 146,
where threonine was substituted by asparagine (T146N). In 2001,
Schickli et al. [47] detected an asparagine instead of the
threonine and lysine at this position (T146N, K147-). Further-
more, they described a second substitution D204E present in this
virus strain (passage 1). The third substitution was located at
position 158, where lysine was substituted by glutamic acid
(K158E).
In summary, the genome sequences of RNA segment 4, coding
for HA, are homogenous in the initial virus seed of the RKI-strain
(passage 1). This suggests clearly that the virus seed consisted of
only one population. The adaptation processes resulted in
additional virus variants, due to mutations in the HA stem region.
However, no potential HA N-glycosylation sites or amino acids in
their close neighborhood were affected. In contrast, the initial
virus seed population (passage 1) of the NIBSC-strain of the
adaptation series comprises more subpopulations concerning the
HA-encoding RNA segment 4 than the RKI virus seed.
Previously, these two (theoretical identical) influenza virus seeds
have been described to differ significantly in infection character-
istics such as interferon (IFN) and apoptosis induction, expression
of interferon stimulated genes, final virus yields [48,49], and the
activation of general host cell response [50,51]: PR/8/34 from
NIBSC was characterized to induce higher levels of IFN and Mx
expression, to induce apoptosis earlier, and to reach lower final
titers than the PR/8/34 from RKI. Seitz et al. hypothesized that
two amino acid substitutions in the non-structural protein 1 (NS1)
might be related to these differences. Our present findings of a set
of slightly different virus variants in the NIBSC seed suggest that
the lower average virus yields are due to a broadened quasispecies
Table 1. Changes of quasispecies composition on HA level of Influenza A/PR/8/34 (H1N1) (RKI, A) and (NIBSC, B) during virus
adaptation.
A DNA Level Protein Level Passage 1 Passage 6 Passage 11
Base Substitution Amino Acid Substitution Population Ratio [%] Population Ratio [%] Population Ratio [%]
C 1370 T S 457 L 0 19 9
A 1378 G K 460 E 0 80 81
no (initial seed virus) no AA-substitutions 100 few reads 10
B DNA Level Protein Level Passage 1 Passage 6 Passage 11
Base Substitution Amino Acid Substitution Population Ratio [%] Population Ratio [%] Population Ratio [%]
T 7 0C Y 2 4H 2 2 0 0
G 1183 A V 395 M 0 41,5 11,3
A 1189 G T 397 A 1,3 0 0
A 1189 T T 397 S 0,6 0 5,4
G 1363 T D 455 Y 21,4 6,1 3,2
G 1363 C D 455 H 0 52 44,1
A 1375 G K 459 E 0 0 44,2
A 1378 G N 460 D 12,2 41,1 10,5
Passage 1 represents the MDCK cell adapted seed virus. Passage 6 represents the last of five successive virus passages in Vero cells. Passage 11 represents the last of five
subsequent passages in MDCK cells, i.e. after final back-adaptation. 0% values correspond to below the detection limit. (A) In passage 6 and 11 of the PR/8/34 (RKI) the
two substitutions at amino acid positions 457 and 460 are uncoupled. (B) In the first passage of the PR/8/34 (NIBSC) the two substitutions D455Y and N460D are
uncoupled.
doi:10.1371/journal.pone.0027989.t001
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virus variants. The heterogeneity of PR/8/34 (NIBSC) persisted
during the whole adaptation processes: from passage 1 to 11,
samples comprised multiple virus subpopulations. Thereby, sizes
of subpopulations as well as selection and extinction of specific
virus variants varied in dependence of adaptation pressure, i.e. the
host. Similar findings were reported by Bull et al. for adaptation
studies with bacteriophages. They observed the highest level of
convergence for bacteriophages grown on the same host and
furthermore finally deduced that most substitutions during forward
and backward adaptation to different hosts were most probably
driven by the adaptation pressure of host-switching [52].
A comparison of results of both adaptation experiments with
influenza virus strains from NIBSC and from RKI shows one
interesting similarity, the substitution of lysine by glutamic acid. In
particular, the K459E variant from NIBSC that carries a deletion
in the HA1 chain (K147-) corresponds to the K460E variant from
the RKI. Moreover, also the substitutions D455H and N460D of
the NIBSC strain are located in the same region of the HA2
subunit as the substitutions S457L and K460E of the RKI-strain.
For both influenza virus strains the amino acid substitutions in
HA during virus adaptation are located exclusively in the HA2
chain (figure S4). Rott et al. [53] described the occurrence of virus
variants after adaptation to MDCK cells, which exhibited elevated
fusion pH, though these carried exclusively substitutions within the
HA1 chain. In contrast, our experiments indicate a crucial role of
the HA stem region for virus adaptation from MDCK to Vero
cells. Here, inter-monomer or inter-subunit contact is mediated,
suggesting HA-initiated fusion as a driving factor of adaptation
pressure. Both adaptation series show a significant change of the
HA N-glycosylation pattern with the change of host cell system.
Additionally, both experiments demonstrate that only a small
sequence adaptation is required for successful infection and fast
growth to high titers in new host cell lines. These findings are in
agreement with results of Wagner et al. and Klenk et al. [45,54]
who reported that N-glycans attached to the stem domain of HA
efficiently regulate influenza A virus replication. The authors
showed that a loss of N-glycans in the stem region results in
increased pH-sensitivity of the virus and that these viruses are also
temperature sensitive.
Taken together, our data show that a MDCK cell-adapted virus
seed that had not been exposed to Vero cells before, hardly
produces any virus progeny in Vero cells. Nevertheless, amino acid
substitutions within the stem region of HA can rescue the virus
population and ensure efficient virus replication in the new host.
Interestingly, for both RKI- and NIBSC-derived virus strains the
glycan pattern stabilized with the first passage in the new cell line,
with all passage to passage SDs values below 8.5%. The faster
release of virus particles and to begin with the further increase in
HA-titers during passages two to six indicates that other factors are
as well involved in the adaptation process, i.e. changes in the
sequence of the viral genome resulting in improved fitness of virus
subpopulations. In agreement with Schwarzer et al. the HA glycan
profile of Vero cell-adapted virus shows a tendency towards
smaller glycan structures compared to MDCK cell-derived viruses
[31]. The fitness of these adapted virus variants during backward
adaptation to MDCK cells varies – some variants as the K460E
(RKI) replicate well and infect either cell line while others grow
only poorly in one cell line (e.g. S457L (RKI) in MDCK cells).
Whether the substitutions that occurred during the adaptation
processes alter acid stability [43], pH of activation, or membrane
fusion mechanism [44] of HA or simply counteract steric
hindrance caused by Vero-specific changes in N-glycosylation on
residues 28 and/or 40 in the stem region of HA for achieving a
low-pH conformation, remains to be further elucidated. Finally it
should be pointed out, that other factors besides the adaptation
status to a host cell line contribute to HA N-glycosylation. Besides
the host cell itself - as demonstrated by Schwarzer et al. [31] - one
may have to include differences in cell culture media, cultivation
systems and cultivation conditions, virus seed preparation, cell
density and multiplicity of infection used in the virus production
phase. Furthermore, little is known concerning the impact of
changes in glycan profiles on properties of live and dead vaccines,
i.e. safety and immunogenicity. Nevertheless, monitoring HA N-
glycosylation patterns during vaccine production processes allows
not only to investigate the impact of process modifications on
antigen quality, but also offers a sensitive tool to evaluate
consequences of unwanted process variations or process failures.
Supporting Information
Figure S1 Stability of HA N-glycosylation patterns of
influenza A/PR/8/34 (H1N1, RKI). (A) The shifted overlays
of normalized capillary electropherograms demonstrate reproduc-
ible HA N-glycosylation patterns over 10 successive virus passages
in MDCK cells. The relative fluorescence units (RFU) are plotted
over the normalized migration time in basepairs (bp). All 10
patterns exhibit the same 15 numbered main peaks between 300
bp and 420 bp. (B) Relative peak heights (RPH) of the 15 main
peaks. Standard deviations (error bars) for 10 successive virus
passages, range between 0.25% and 1.14%. The corresponding
relative standard deviations (RSD) of low abundant peaks, (each
representing less than 5% of the total peak heights (TPH);
numbered 1, 7, 9, 14, 16) range between 8.16% and 23.64%,
while the RSD for all high abundant peaks (each representing
more than 5% of TPH) range between 4.16% and 7.65%.
(TIF)
Figure S2 Impact of harvest time point on the HA N-
glycosylation pattern of MDCK cell-derived influenza A
PR/8/34 (H1N1, RKI). (A) Relative fluorescence units (RFU)
are plotted over the normalized migration time in basepairs (bp).
The shifted overlay of normalized capillary electropherograms
demonstrates an overall stability of the HA N-glycosylation pattern
within the range from 24 hpi to 96 hpi. Both harvest time points
exhibited the same 15 numbered main peaks (peak no.: 1-4, 6-16,
cf. figure 1) with migration times between 300 bp and 420 bp. (B)
The relative peak heights (RPH) of the 15 dominating peaks (no.:
1-4, 6-16) are represented by grey (24 hpi) or white (96 hpi)
columns; corresponding average values (3) with the respective
standard deviations (error bars) are indicated in black.
(TIF)
Figure S3 Impact of harvest time point on the HA N-
glycosylation pattern of Vero cell-derived influenza A
PR/8/34 (H1N1, RKI). (A) Relative fluorescence units (RFU)
are plotted over the normalized migration time in basepairs (bp).
The shifted overlay of normalized capillary electropherograms
demonstrates an overall stability of the HA N-glycosylation pattern
from 48 hpi to 360 hpi. The harvest time point has an impact on
the RPH of the 16 numbered main peaks (peak no.: 5, 7, 8, 11, 15-
25), exhibiting normalized migration times between 220 bp and
380 bp. (B) For each harvest time point, the relative peak heights
(RPH) of all 16 dominating peaks (no.: 5, 7, 8, 11, 15-25) are
represented by a column. Corresponding average values (3) and
standard deviations (error bars) are indicated in grey.
(TIF)
Figure S4 Localization of substitutions during adapta-
tion within the 3D HA-stucture. Structures are disolayed in a
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lighted by red space filled residues. (A, B, C, D) Influenza A/PR/
8/34 (H1N1, RKI), (E, F, G, H) influenza A/PR/8/34 (H1N1,
NIBSC). Trimeric (A-C, E-G) and monomeric (D, H) HA
molecules. (A-D) The HA1 chains are colored in pink, green
and brown; the HA2 chains are colored in blue, grey and orange.
The K460E mutation is highlighted in yellow, the S457L
substitution by white space-filled residues. (A) Bottom (B) side
and (C) top view. (D) indicates the close proximity within the
monomer of these two substitutions, which are one helix turn
apart from each other. (E-H) For the isolate from NIBSC the HA1
chains are colored in pink, purple and green; the HA2 chains are
colored in turquoise, yellow and orange. The substitutions already
present in the virus seed are highlighted by grey (Y24H), yellow
(D455Y) and pink (N460D) space-filled residues. Substitutions
occurring during virus adaptation are indicated by white (V395M,
T397S) or yellow (D455H) space-filled residues. (E) Top, (F, H)
side, (G) bottom view. The PDB entry 1RU7 and PyMOL (v0.99,
DeLano Scientific LLC, California, USA) software was used for
structure display.
(TIF)
Figure S5 Alignment of HA amino acid consensus
sequences of two closely related influenza viruses A/
PR/8/34 (H1N1). The virus seed of RKI (Amp. 3138)
corresponds to a homogeneous population. Substitutions in the
sequence during the virus adaptation processes are indicated in
red. In contrast, the virus seed from NIBSC (#06/114) comprises
various virus variants; substitutions in the sequence are indicated
in green. The positions of substitutions, acquired during the
adaptation processes are indicated in blue. The amino acid
assembly was performed at http://services.uniprot.org/clustalw.
(TIF)
Table S1 Accession numbers for influenza A virus PR/
8/34 sequences during adaptation from MDCK to Vero
cells and back. The original virus seed was either purchased
from the National Institute for Biological Standards and Control
(NIBSC) or the Robert Koch Institute (RKI). The first virus
passages, produced in MDCK cell culture (M1), served as virus
seed for the first pasages in Vero cells. The last of five consecutive
Vero cell-derived virus passages (V5) served as seed for five
consecutive MDCK cell-derived virus passages, of which M6
represents the last. All sequences were generated by pyrosequenc-
ing and deposited in the GISAID EpiFlu database (www.gisaid.
org).
(PDF)
Table S2 Overview of relative peak heights (RPH)
averages and according standard (SD) and relative
standard deviations (RSD). The average RPH and the
respective SD and RSD of each peak (no. 1 - 25) within each
experiment (control 1: pattern stability for ten consecutive virus
passages; control 2: reproducibility in Vero or MDCK time series;
adaptation series of H1N1 from RKI and adaptation series of
H1N1 from NIBSC) are listed. The factors indicate x–fold increase
(.1) or dercease (,1) of respective deviations observed during
adaptation compared to the maximal deviation during controls.
Factors of . 3 are defined as significantly influenced during
adaptation and highlighted in blue bold numbers.
(PDF)
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